La Croix Saint Ouen, France

Jacques Biton


Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 25(Granted Patents)


Location History:

  • La Croix Saint Quen, FR (1998)
  • La Croix Saint Ouen, FR (1990 - 2007)

Company Filing History:


Years Active: 1990-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jacques Biton - A Pioneer in Pharmaceutical Innovations

Introduction

Jacques Biton is an accomplished inventor hailing from La Croix Saint Ouen, France. With a total of five patents to his name, he has made significant contributions to the pharmaceutical industry, particularly in the development of innovative processes for drug preparation.

Latest Patents

Among his latest inventions, Jacques Biton is credited with patents that detail a process for the preparation of Fexofenadine. This innovative method utilizes bioconversion with a microorganism culture to transform a compound of a specific formula. Furthermore, his work encompasses an efficient bioconversion process leveraging both the LCP 63-1800 and NRRL 2364 strains to derive Fexofenadine from Terfenadine.

Career Highlights

Throughout his career, Jacques has worked with notable companies in the pharmaceutical sector, including Roussel Uclaf and Aventis Pharma S.A. His research and development efforts have positioned him as a significant player in the field, furthering advancements in drug formulation and processing.

Collaborations

In his journey as an inventor, Jacques Biton has collaborated with esteemed colleagues, such as Robert Azerad and Isabelle Lacroix. Their combined expertise has undoubtedly contributed to the innovative solutions that have emerged from their work.

Conclusion

Jacques Biton's dedication to pharmaceutical innovation is reflected in his impactful patents and collaborations. As he continues to explore new avenues in drug development, his contributions serve as a testament to the importance of creativity and research in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…